dopamimetic
Bluelighter
So it looks like racetams are kinda of an antagonist to nmda antagonism, they tend to reverse their effects completely which an agonist probably wouldn't do(?) but to be toxic(?).
Just found this:
I never used racetams since they have strong adverse effects to me, it's long since but what I remember is pretty much of what I use NMDA antagonists against, which kinda makes sense. Heavy dysphoric inner tension, "over-association" (thinking about the past, about others, etc) and stuff alike. I used to think that I just don't react good to increased cholinergic transmission as racetams usually are described as cholinergics, some as AMPAkines but never really read about NMDA. Thought too that NMDA antagonism increases the ratio of AMPA to NMDA activity so AMPAkines shouldn't really have bad effects at low dosages (??)
The point about normalizing enhanced affinity (in aged mice) is interesting. If this is true too in some psychiatric conditions, then this would fit with both my good experiences w/dissos and the theory about NMDA subfunction = psychosis ... Are there other substances with this effect?
--
Sorry, other thing for which I didn't want to open yet another thread. D-cycloserine, a weak partial NMDA agonist with supposedly anxiolytic effects. The agonist part was enough to scare me away but might this be something like the ultra low dose naltrexone of dissociatives, actively lowering tolerance and increasing effects?? The anxiolytic thing sounds quite plausible.
Ok, this doesn't sound too good:
Just that for me I would've thought otherwise. With less NMDA activity I'd press that lever many times more often but guess the rat's situation is a bit different and it tries to escape the heavy stress by getting some reward stimuli and the disso just let 'em drift away ...
Just found this:
Subchronic treatment of aged mice with piracetam (500 mg/kg p.o. for 14 days) elevates N-methyl-D-aspartate (NMDA) receptor density by about 20% and normalizes the enhanced affinity of L-glutamate for the NMDA receptor. Since deficits at the level of the NMDA receptor might be one of the mechanisms underlying age-associated cognitive impairment, the effects reported for piracetam may be relevant for the cognition-enhancing properties of this drug.
I never used racetams since they have strong adverse effects to me, it's long since but what I remember is pretty much of what I use NMDA antagonists against, which kinda makes sense. Heavy dysphoric inner tension, "over-association" (thinking about the past, about others, etc) and stuff alike. I used to think that I just don't react good to increased cholinergic transmission as racetams usually are described as cholinergics, some as AMPAkines but never really read about NMDA. Thought too that NMDA antagonism increases the ratio of AMPA to NMDA activity so AMPAkines shouldn't really have bad effects at low dosages (??)
The point about normalizing enhanced affinity (in aged mice) is interesting. If this is true too in some psychiatric conditions, then this would fit with both my good experiences w/dissos and the theory about NMDA subfunction = psychosis ... Are there other substances with this effect?
--
Sorry, other thing for which I didn't want to open yet another thread. D-cycloserine, a weak partial NMDA agonist with supposedly anxiolytic effects. The agonist part was enough to scare me away but might this be something like the ultra low dose naltrexone of dissociatives, actively lowering tolerance and increasing effects?? The anxiolytic thing sounds quite plausible.
Ok, this doesn't sound too good:
The effects of pharmacologically manipulating N-methyl-D-aspartate(NMDA)-receptor activity were examined during extinction of an appetitive instrumental response in rats. After reaching acquisition criterion, subjects were treated with the antagonist dizocilpine maleate (MK801; 0.1 mg/kg), the agonist D-cycloserine (3 mg/kg), or vehicle-alone (control) and tested during a non-reinforced (extinction) session. The antagonist decreased the average number of responses occurring during the test session whereas the agonist increased the average number in contrast to controls. The effect on retention performance may be mediated by differential influence on the N-methyl-D-aspartate-dependent synaptic plasticity that occurs during associative learning. In conjunction with other studies, these data suggest that N-methyl-D-aspartate agonism may be an effective intervention for memory dysfunction.
Just that for me I would've thought otherwise. With less NMDA activity I'd press that lever many times more often but guess the rat's situation is a bit different and it tries to escape the heavy stress by getting some reward stimuli and the disso just let 'em drift away ...
Last edited: